Edition: Global  
One News Page
“Probably the fastest-access news portal in the world”
> >

Seres Therapeutics Reports Third Quarter 2017 Financial Results and Provides Update on Operational Progress

Business Wire Wednesday, 8 November 2017 ()
Seres Therapeutics Reports Third Quarter 2017 Financial Results and Provides Update on Operational ProgressCAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc., today reported third quarter 2017 financial results and provided a progress update on multiple microbiome clinical programs.
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

You Might Like


Recent related news

Xenetic Biosciences Reports 2017 Third Quarter Financial Results and Provides Corporate Update

LEXINGTON, Mass.--(BUSINESS WIRE)--Xenetic Biosciences, Inc. (NASDAQ: XBIO) (“Xenetic” or the “Company”), a clinical-stage biopharmaceutical company...
Business Wire - Press ReleasesAlso reported by •GlobeNewswirePR Newswire AsiaMarketwiredFinanzNachrichten.de

10 Things to Know About SBS Transit Ltd’s Latest Earnings

Here’s a quick update on SBS Transit Ltd’s (SGX: S61) third quarter financial results.
Motley Fool - Markets


Other recent news in Press Releases

Sigma Announces Company's Biggest BLACK FRIDAY Sale on Award-Winning Art LensesVital Insurance Agency Initiates Charity Drive to Promote Swimming Lessons for Young Children in the CHICAGO Area
The Tennessee River VALLEY Stewardship Council Celebrates the One Year Anniversary of the Mapguide ExpansionMetLife Foundation & Verb Launch Competition To Accelerate Financial Innovation In BANGLADESH
SANTA PAWS is Coming to Town. Hollywood RESCUE Grooming Foundation Rolls to Union RESCUE Mission to Groom the Homeless Pets of Skid Row and Toys to the ChildrenTrek Travel Announces 2018 Tour de FRANCE Bike Tours
ANDERSEN Hitches 5th Wheel Hitch Gets The Ultimate Revamp

Twitter

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+